{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:35:56Z","timestamp":1792992956946,"version":"4.5.0"},"reference-count":76,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.25122\/jml-2026-0098","type":"journal-article","created":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:05:41Z","timestamp":1792991141000},"page":"657-671","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 severity and early inflammatory biomarkers in patients with immune-mediated inflammatory rheumatic diseases: a multicenter cohort study"],"prefix":"10.25122","volume":"19","author":[{"given":"Andreea-Valentina","family":"Suciu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Giuvar\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea-Iulia","family":"Vl\u0103dulescu-Trandafir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelu","family":"Onose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta-Claudia","family":"Bojinc\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Internal Medicine and Rheumatology, Sf\u00e2nta Maria Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medical Bioengineering, Grigore T. Popa University of Medicine and Pharmacy, Ia\u0219i, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneliu-Dan","family":"Blendea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Clinical Regional Emergency Hospital Ilfov, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuromuscular Rehabilitation Clinic Division, Bagdasar-Arseni Teaching Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41584-022-00755-x","article-title":"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations","volume":"18","author":"Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC","year":"2022","unstructured":"1. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC, COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations, Nat Rev Rheumatol, 2022;18(4):191-204","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"ref2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.42030","article-title":"SARS-CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis","volume":"74","author":"Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-Garc\u00eda A, Tseng LY","year":"2022","unstructured":"2. Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-Garc\u00eda A, Tseng LY, SARS-CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis, Arthritis Rheumatol, 2022;74(5):766-75","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"101657","DOI":"10.1016\/j.berh.2020.101657","article-title":"Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes","volume":"35","author":"Grainger R, Machado PM, Robinson PC","year":"2021","unstructured":"3. Grainger R, Machado PM, Robinson PC, Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes, Best Pract Res Clin Rheumatol, 2021;35(1):101657","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/ard-2023-223974","article-title":"Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study","volume":"82","author":"Svensson ALL, Emborg HD, Bartels LE, Ellingsen T, Adelsten T, Cordtz R","year":"2023","unstructured":"4. Svensson ALL, Emborg HD, Bartels LE, Ellingsen T, Adelsten T, Cordtz R, Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study, Ann Rheum Dis, 2023;82(10):1359-67","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.1016\/S2665-9913(22)00098-4","article-title":"Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform","volume":"4","author":"MacKenna B, Kennedy NA, Mehrkar A, Rowan A, Galloway J, Matthewman J","year":"2022","unstructured":"5. MacKenna B, Kennedy NA, Mehrkar A, Rowan A, Galloway J, Matthewman J, Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform, Lancet Rheumatol, 2022;4(7):e490-506","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"ref6","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/S2665-9913(21)00112-0","article-title":"SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study","volume":"3","author":"Saadoun D, Vieira M, Vautier M, Baraliakos X, Andreica I, da Silva JAP","year":"2021","unstructured":"6. Saadoun D, Vieira M, Vautier M, Baraliakos X, Andreica I, da Silva JAP, SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study, Lancet Rheumatol, 2021;3(7):e481-8","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/mr\/roac148","article-title":"Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicentre registry","volume":"34","author":"Boteanu A, Leon L, Esteban SP, Rubio ER, Pascual MP, Bonilla G","year":"2023","unstructured":"7. Boteanu A, Leon L, Esteban SP, Rubio ER, Pascual MP, Bonilla G, Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicentre registry, Mod Rheumatol, 2023;34(1):97-105","journal-title":"Mod Rheumatol"},{"issue":"5","key":"ref8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.semarthrit.2021.08.010","article-title":"Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States","volume":"51","author":"Raiker R, DeYoung C, Pakhchanian H, Ahmed S, Kavadichanda C, Gupta L","year":"2021","unstructured":"8. Raiker R, DeYoung C, Pakhchanian H, Ahmed S, Kavadichanda C, Gupta L, Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States, Semin Arthritis Rheum, 2021;51(5):1057-66","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5114\/reum\/183469","article-title":"COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion","volume":"62","author":"Kwiatkowska B, Krajewska-W\u0142odarczyk M, Batko B, Ma\u015bli\u0144ska M, Stajszczyk M, \u015awierkot J","year":"2024","unstructured":"9. Kwiatkowska B, Krajewska-W\u0142odarczyk M, Batko B, Ma\u015bli\u0144ska M, Stajszczyk M, \u015awierkot J, COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion, Reumatologia, 2024;62(1):4-17","journal-title":"Reumatologia"},{"issue":"24","key":"ref10","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.3390\/jcm11247342","article-title":"The course of COVID-19 in patients with systemic autoimmune rheumatic diseases","volume":"11","author":"Rorat M, Zar\u0119bska-Michaluk D, Kowalska J, Kujawa K, Rogalska M, Kozielewicz D","year":"2022","unstructured":"10. Rorat M, Zar\u0119bska-Michaluk D, Kowalska J, Kujawa K, Rogalska M, Kozielewicz D, The course of COVID-19 in patients with systemic autoimmune rheumatic diseases, J Clin Med, 2022;11(24):7342","journal-title":"J Clin Med"},{"issue":"12","key":"ref11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3390\/healthcare9121707","article-title":"COVID-19 impact and vaccination willingness among Romanian patients with autoimmune\/immune-mediated diseases","volume":"9","author":"Pinte L, Caraiola S, Balaban DV, Badea C, Mazilu D, Ionescu GD","year":"2021","unstructured":"11. Pinte L, Caraiola S, Balaban DV, Badea C, Mazilu D, Ionescu GD, COVID-19 impact and vaccination willingness among Romanian patients with autoimmune\/immune-mediated diseases, Healthcare (Basel), 2021;9(12):1707","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/medicina61030411","article-title":"Predictive factors for COVID-19 severity in patients with axial spondyloarthritis: real-world data from the Romanian Registry of Rheumatic Diseases","volume":"61","author":"Vl\u0103dulescu-Trandafir AI, Bojinc\u0103 VC, Popescu C, Munteanu C, B\u0103l\u0103nescu AR, Anghelescu A","year":"2025","unstructured":"12. Vl\u0103dulescu-Trandafir AI, Bojinc\u0103 VC, Popescu C, Munteanu C, B\u0103l\u0103nescu AR, Anghelescu A, Predictive factors for COVID-19 severity in patients with axial spondyloarthritis: real-world data from the Romanian Registry of Rheumatic Diseases, Medicina (Kaunas), 2025;61(3):411","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"ref13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld A, Sch\u00e4fer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L","year":"2021","unstructured":"13. Strangfeld A, Sch\u00e4fer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry, Ann Rheum Dis, 2021;80(7):930-42","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00296-021-04803-9","article-title":"Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis","volume":"41","author":"Wang Q, Liu J, Shao R, Han X, Su C, Lu W","year":"2021","unstructured":"14. Wang Q, Liu J, Shao R, Han X, Su C, Lu W, Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis, Rheumatol Int, 2021;41(5):851-61","journal-title":"Rheumatol Int"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12985-023-02116-w","article-title":"Neutrophils in COVID-19: recent insights and advances","volume":"20","author":"Li J, Zhang K, Zhang Y, Gu Z, Huang C","year":"2023","unstructured":"15. Li J, Zhang K, Zhang Y, Gu Z, Huang C, Neutrophils in COVID-19: recent insights and advances, Virol J, 2023;20(1):169","journal-title":"Virol J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"807332","DOI":"10.3389\/fcimb.2022.807332","article-title":"Inflammation\/coagulopathy\/immunology responsive index predicts poor COVID-19 prognosis","volume":"12","author":"An H, Zhang J, Li T, Hu Y, Wang Q, Chen C","year":"2022","unstructured":"16. An H, Zhang J, Li T, Hu Y, Wang Q, Chen C, Inflammation\/coagulopathy\/immunology responsive index predicts poor COVID-19 prognosis, Front Cell Infect Microbiol, 2022;12807332","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1038908","DOI":"10.3389\/fcimb.2022.1038908","article-title":"COVID-19 biomarkers: what did we learn from systematic reviews?","volume":"12","author":"Semiz S","year":"2022","unstructured":"17. Semiz S, COVID-19 biomarkers: what did we learn from systematic reviews?, Front Cell Infect Microbiol, 2022;121038908","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1065345","DOI":"10.3389\/fimmu.2022.1065345","article-title":"The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients","volume":"13","author":"Qiu W, Shi Q, Chen F, Wu Q, Yu X, Xiong L","year":"2022","unstructured":"18. Qiu W, Shi Q, Chen F, Wu Q, Yu X, Xiong L, The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients, Front Immunol, 2022;131065345","journal-title":"Front Immunol"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s13054-020-03374-8","article-title":"Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"24","author":"Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S","year":"2020","unstructured":"19. Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis, Crit Care, 2020;24(1):647","journal-title":"Crit Care"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/jmv.27275","article-title":"A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators","volume":"94","author":"Tang F, Zhang X, Zhang B, Zhu B, Wang J","year":"2022","unstructured":"20. Tang F, Zhang X, Zhang B, Zhu B, Wang J, A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators, J Med Virol, 2022;94(1):131-40","journal-title":"J Med Virol"},{"issue":"14","key":"ref21","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.3390\/jcm12144584","article-title":"Aggregate index of systemic inflammation (AISI), disease severity, and mortality in COVID-19: a systematic review and meta-analysis","volume":"12","author":"Zinellu A, Paliogiannis P, Mangoni AA","year":"2023","unstructured":"21. Zinellu A, Paliogiannis P, Mangoni AA, Aggregate index of systemic inflammation (AISI), disease severity, and mortality in COVID-19: a systematic review and meta-analysis, J Clin Med, 2023;12(14):4584","journal-title":"J Clin Med"},{"issue":"7","key":"ref22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L","year":"2020","unstructured":"22. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry, Ann Rheum Dis, 2020;79(7):859-66","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref23","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s10067-022-06087-1","article-title":"Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis","volume":"41","author":"Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H","year":"2022","unstructured":"23. Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H, Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis, Clin Rheumatol, 2022;41(7):2213-23","journal-title":"Clin Rheumatol"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/keac422","article-title":"Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study","volume":"62","author":"Bournia VK, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G","year":"2023","unstructured":"24. Bournia VK, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study, Rheumatology (Oxford), 2023;62(3):1047-56","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"ref25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/10543406.2025.2489288","article-title":"Comparison of continuous, binary, and ordinal endpoints","volume":"35","author":"Zhai J, Smith F, Soon G","year":"2025","unstructured":"25. Zhai J, Smith F, Soon G, Comparison of continuous, binary, and ordinal endpoints, J Biopharm Stat, 2025;35(6):1143-60","journal-title":"J Biopharm Stat"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10519-020-10031-x","article-title":"Best Practices for Binary and Ordinal Data Analyses","volume":"51","author":"Verhulst B, Neale MC","year":"2021","unstructured":"26. Verhulst B, Neale MC, Best Practices for Binary and Ordinal Data Analyses, Behav Genet, 2021;51(3):204-214","journal-title":"Behav Genet"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.12680\/balneo.2026.965","article-title":"Mapping early COVID-19 clinical and laboratory profiles in patients with immune-mediated inflammatory rheumatic diseases: a multicenter case-control study","volume":"17","author":"Vl\u0103dulescu-Trandafir AI, Onose G, Bojinc\u0103 VC, Mirea A, Aurelian SM, Munteanu C","year":"2026","unstructured":"27. Vl\u0103dulescu-Trandafir AI, Onose G, Bojinc\u0103 VC, Mirea A, Aurelian SM, Munteanu C, Mapping early COVID-19 clinical and laboratory profiles in patients with immune-mediated inflammatory rheumatic diseases: a multicenter case-control study, Balneo PRM Res J, 2026;17(1):965","journal-title":"Balneo PRM Res J"},{"key":"ref28","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2024","unstructured":"28. R Core Team, R: a language and environment for statistical computing, [Internet], Vienna (Austria):R Foundation for Statistical Computing, 2024;Available from: https:\/\/www.r-project.org\/","journal-title":"[Internet]"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"111507","DOI":"10.1016\/j.exger.2021.111507","article-title":"Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: the role of entangled risk factors","volume":"154","author":"Farshbafnadi M, Kamali Zonouzi S, Sabahi M, Dolatshahi M, Aarabi MH","year":"2021","unstructured":"29. Farshbafnadi M, Kamali Zonouzi S, Sabahi M, Dolatshahi M, Aarabi MH, Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: the role of entangled risk factors, Exp Gerontol, 2021;154111507","journal-title":"Exp Gerontol"},{"issue":"12","key":"ref30","doi-asserted-by":"publisher","first-page":"e006434","DOI":"10.1136\/bmjgh-2021-006434","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Starke KR, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A","year":"2021","unstructured":"30. Starke KR, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A, The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis, BMJ Glob Health, 2021;6(12):e006434","journal-title":"BMJ Glob Health"},{"issue":"21","key":"ref31","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1080\/10408398.2021.2012419","article-title":"Association between vitamin D status and risk of COVID-19 in-hospital mortality: a systematic review and meta-analysis of observational studies","volume":"63","author":"Ebrahimzadeh A, Mohseni S, Narimani B, Ebrahimzadeh A, Kazemi S, Keshavarz F","year":"2023","unstructured":"31. Ebrahimzadeh A, Mohseni S, Narimani B, Ebrahimzadeh A, Kazemi S, Keshavarz F, Association between vitamin D status and risk of COVID-19 in-hospital mortality: a systematic review and meta-analysis of observational studies, Crit Rev Food Sci Nutr, 2023;63(21):5033-43","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6-7","key":"ref32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00726-020-02870-z","article-title":"SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age","volume":"52","author":"Vuille-dit-Bille RN, Liechty KW, Verrey F, Guglielmetti LC","year":"2020","unstructured":"32. Vuille-dit-Bille RN, Liechty KW, Verrey F, Guglielmetti LC, SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age, Amino Acids, 2020;52(6-7):1063-5","journal-title":"Amino Acids"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"e0247060","DOI":"10.1371\/journal.pone.0247060","article-title":"Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation","volume":"16","author":"Baker SA, Kwok S, Berry GJ, Montine TJ","year":"2021","unstructured":"33. Baker SA, Kwok S, Berry GJ, Montine TJ, Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation, PLoS One, 2021;16(2):e0247060","journal-title":"PLoS One"},{"issue":"11","key":"ref34","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/jmv.26174","article-title":"Clinical characteristics of COVID-19 in patients with preexisting ILD: a retrospective study in a single center in Wuhan, China","volume":"92","author":"Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J","year":"2020","unstructured":"34. Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J, Clinical characteristics of COVID-19 in patients with preexisting ILD: a retrospective study in a single center in Wuhan, China, J Med Virol, 2020;92(11):2742-50","journal-title":"J Med Virol"},{"issue":"6","key":"ref35","doi-asserted-by":"publisher","first-page":"2004125","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","volume":"58","author":"Lee H, Choi H, Yang B, Lee SK, Park TS, Park DW","year":"2021","unstructured":"35. Lee H, Choi H, Yang B, Lee SK, Park TS, Park DW, Interstitial lung disease increases susceptibility to and severity of COVID-19, Eur Respir J, 2021;58(6):2004125","journal-title":"Eur Respir J"},{"issue":"167","key":"ref36","doi-asserted-by":"publisher","first-page":"220210","DOI":"10.1183\/16000617.0210-2022","article-title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","volume":"32","author":"Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM","year":"2023","unstructured":"36. Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis, Eur Respir Rev, 2023;32(167):220210","journal-title":"Eur Respir Rev"},{"issue":"8","key":"ref37","doi-asserted-by":"publisher","first-page":"CD015050","DOI":"10.1002\/14651858.CD015050.pub2","article-title":"Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2","volume":"2024","author":"De Rop L, Bos DAG, Stegeman I, Holtman G, Ochodo EA, Spijker R","year":"2024","unstructured":"37. De Rop L, Bos DAG, Stegeman I, Holtman G, Ochodo EA, Spijker R, Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2, Cochrane Database Syst Rev, 2024;2024(8):CD015050","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref38","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/00365513.2021.2000635","article-title":"CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients","volume":"81","author":"Wang L, Yang LM, Pei SF, Chong YZ, Guo Y, Gao XL","year":"2021","unstructured":"38. Wang L, Yang LM, Pei SF, Chong YZ, Guo Y, Gao XL, CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients, Scand J Clin Lab Invest, 2021;81(8):679-86","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"ref39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers associated with COVID-19 disease progression","volume":"57","author":"Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T","year":"2020","unstructured":"39. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T, Biomarkers associated with COVID-19 disease progression, Crit Rev Clin Lab Sci, 2020;57(6):389-99","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajem.2020.12.076","article-title":"Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis","volume":"41","author":"Hariyanto TI, Japar KV, Kwenandar F, Damay V, Siregar JI, Lugito NPH, Tjiang MM, Kurniawan A","year":"2021","unstructured":"40. Hariyanto TI, Japar KV, Kwenandar F, Damay V, Siregar JI, Lugito NPH, Tjiang MM, Kurniawan A, Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis, Am J Emerg Med, 2021;41110-119","journal-title":"Am J Emerg Med"},{"issue":"9","key":"ref41","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s10067-020-05301-2","article-title":"Determinants of COVID-19 disease severity in patients with underlying rheumatic disease","volume":"39","author":"Santos CS, Morales CM, \u00c1lvarez ED, Castro C\u00c1, Robles AL, Sandoval TP","year":"2020","unstructured":"41. Santos CS, Morales CM, \u00c1lvarez ED, Castro C\u00c1, Robles AL, Sandoval TP, Determinants of COVID-19 disease severity in patients with underlying rheumatic disease, Clin Rheumatol, 2020;39(9):2789-2796","journal-title":"Clin Rheumatol"},{"issue":"9","key":"ref42","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/S2665-9913(21)00140-5","article-title":"Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study","volume":"3","author":"Hsu TYT, D\u2019Silva KM, Patel NJ, Wang J, Mueller AA, Fu X","year":"2021","unstructured":"42. Hsu TYT, D\u2019Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study, Lancet Rheumatol, 2021;3(9):e638-47","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"ref43","doi-asserted-by":"publisher","first-page":"e2020008","DOI":"10.23750\/abm.v91i3.10217","article-title":"Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis","volume":"91","author":"Henry BM, Cheruiyot I, Vikse J, Mutua V, Kipkorir V, Benoit J","year":"2020","unstructured":"43. Henry BM, Cheruiyot I, Vikse J, Mutua V, Kipkorir V, Benoit J, Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis, Acta Biomed, 2020;91(3):e2020008","journal-title":"Acta Biomed"},{"issue":"7","key":"ref44","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M","year":"2020","unstructured":"44. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Hematological findings and complications of COVID-19, Am J Hematol, 2020;95(7):834-47","journal-title":"Am J Hematol"},{"issue":"6","key":"ref45","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1002\/ajh.25774","article-title":"Hematologic parameters in patients with COVID-19 infection","volume":"95","author":"Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB","year":"2020","unstructured":"45. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, Hematologic parameters in patients with COVID-19 infection, Am J Hematol, 2020;95(6):E131-4","journal-title":"Am J Hematol"},{"issue":"1","key":"ref46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/diagnostics12010122","article-title":"The predictive role of NLR, dNLR, MLR, and SIRI in COVID-19 mortality","volume":"12","author":"Citu C, Gorun F, Motoc A, Sas I, Gorun OM, Burlea B","year":"2022","unstructured":"46. Citu C, Gorun F, Motoc A, Sas I, Gorun OM, Burlea B, The predictive role of NLR, dNLR, MLR, and SIRI in COVID-19 mortality, Diagnostics (Basel), 2022;12(1):122","journal-title":"Diagnostics (Basel)"},{"issue":"20","key":"ref47","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.3390\/ijms252010905","article-title":"Lymphocytes change their phenotype and function in systemic lupus erythematosus and lupus nephritis","volume":"25","author":"Moysidou E, Christodoulou M, Lioulios G, Stai S, Karamitsos T, Dimitroulas T","year":"2024","unstructured":"47. Moysidou E, Christodoulou M, Lioulios G, Stai S, Karamitsos T, Dimitroulas T, Lymphocytes change their phenotype and function in systemic lupus erythematosus and lupus nephritis, Int J Mol Sci, 2024;25(20):10905","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11658-025-00749-z","article-title":"Immune cell aberrations in systemic lupus erythematosus: navigating the targeted therapies toward precision management","volume":"30","author":"Wu YX, Zhang W, Liao Y, Sun T, Liu Y, Liu Y","year":"2025","unstructured":"48. Wu YX, Zhang W, Liao Y, Sun T, Liu Y, Liu Y, Immune cell aberrations in systemic lupus erythematosus: navigating the targeted therapies toward precision management, Cell Mol Biol Lett, 2025;30(1):73","journal-title":"Cell Mol Biol Lett"},{"issue":"29","key":"ref49","doi-asserted-by":"publisher","first-page":"e43048","DOI":"10.1097\/MD.0000000000043048","article-title":"The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis","volume":"104","author":"Yang X","year":"2025","unstructured":"49. Yang X, The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis, Medicine (Baltimore), 2025;104(29):e43048","journal-title":"Medicine (Baltimore)"},{"issue":"38","key":"ref50","doi-asserted-by":"publisher","first-page":"e44554","DOI":"10.1097\/MD.0000000000044554","article-title":"The neutrophil-to-lymphocyte ratio in rheumatoid arthritis: the dual perspectives from literature and clinic","volume":"104","author":"Li Y, Liu J, Hu Y, Cong C, Chen Y, Fang Y","year":"2025","unstructured":"50. Li Y, Liu J, Hu Y, Cong C, Chen Y, Fang Y, The neutrophil-to-lymphocyte ratio in rheumatoid arthritis: the dual perspectives from literature and clinic, Medicine (Baltimore), 2025;104(38):e44554","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"ref51","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/biomedicines13061497","article-title":"Neutrophil\u2013lymphocyte ratio in fibromyalgia and axial spondyloarthritis: a potential biomarker for diagnosis and disease activity","volume":"13","author":"Almirall M, Espartal E, Michelena X, Suso-Ribera C, Serrat M, Marsal S","year":"2025","unstructured":"51. Almirall M, Espartal E, Michelena X, Suso-Ribera C, Serrat M, Marsal S, Neutrophil\u2013lymphocyte ratio in fibromyalgia and axial spondyloarthritis: a potential biomarker for diagnosis and disease activity, Biomedicines, 2025;13(6):1497","journal-title":"Biomedicines"},{"issue":"5","key":"ref52","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jcla.21908","article-title":"The association between neutrophil\/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis","volume":"30","author":"Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA","year":"2016","unstructured":"52. Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, The association between neutrophil\/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis, J Clin Lab Anal, 2016;30(5):597-601","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"ref53","doi-asserted-by":"publisher","first-page":"e13877","DOI":"10.1111\/eci.13877","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio and disease activity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"53","author":"Zinellu A, Mangoni AA","year":"2023","unstructured":"53. Zinellu A, Mangoni AA, Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio and disease activity in rheumatoid arthritis: a systematic review and meta-analysis, Eur J Clin Invest, 2023;53(2):e13877","journal-title":"Eur J Clin Invest"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1395993","DOI":"10.3389\/fimmu.2024.1395993","article-title":"The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis","volume":"15","author":"Zinellu A, Mangoni AA","year":"2024","unstructured":"54. Zinellu A, Mangoni AA, The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis, Front Immunol, 2024;151395993","journal-title":"Front Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","article-title":"Neutrophil extracellular traps (NETs) and COVID-19: a new frontiers for therapeutic modality","volume":"104","author":"Al-Kuraishy HM, Al-Gareeb AI, Al-hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GES","year":"2022","unstructured":"55. Al-Kuraishy HM, Al-Gareeb AI, Al-hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GES, Neutrophil extracellular traps (NETs) and COVID-19: a new frontiers for therapeutic modality, Int Immunopharmacol, 2022;104108516","journal-title":"Int Immunopharmacol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.2147\/IJGM.S326666","article-title":"Validation of neutrophil-to-lymphocyte ratio cut-off value associated with high in-hospital mortality in COVID-19 patients","volume":"14","author":"Yildiz H, Castanares-Zapatero D, Pierman G, Pothen L, De Greef J, Nana FA","year":"2021","unstructured":"56. Yildiz H, Castanares-Zapatero D, Pierman G, Pothen L, De Greef J, Nana FA, Validation of neutrophil-to-lymphocyte ratio cut-off value associated with high in-hospital mortality in COVID-19 patients, Int J Gen Med, 2021;145111-7","journal-title":"Int J Gen Med"},{"issue":"8","key":"ref57","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm11082235","article-title":"Neutrophil-to-lymphocyte ratio (NLR) is a promising predictor of mortality and admission to intensive care unit of COVID-19 patients","volume":"11","author":"Regolo M, Vaccaro M, Sorce A, Stancanelli B, Colaci M, Natoli G","year":"2022","unstructured":"57. Regolo M, Vaccaro M, Sorce A, Stancanelli B, Colaci M, Natoli G, Neutrophil-to-lymphocyte ratio (NLR) is a promising predictor of mortality and admission to intensive care unit of COVID-19 patients, J Clin Med, 2022;11(8):2235","journal-title":"J Clin Med"},{"issue":"7","key":"ref58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/covid5070096","article-title":"Neutrophil-to-lymphocyte ratio predicts COVID-19 mortality in the Yucatecan Maya population: a retrospective cohort study","volume":"5","author":"Alonso Batun AI, Tello Romero VJ, Pacheco Polanco OA, Mendez-Dominguez N","year":"2025","unstructured":"58. Alonso Batun AI, Tello Romero VJ, Pacheco Polanco OA, Mendez-Dominguez N, Neutrophil-to-lymphocyte ratio predicts COVID-19 mortality in the Yucatecan Maya population: a retrospective cohort study, COVID, 2025;5(7):96","journal-title":"COVID"},{"issue":"3","key":"ref59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.18502\/ijaai.v21i3.9798","article-title":"Neutrophil to lymphocyte ratio (NLR) and derived NLR combination: a cost-effective predictor of moderate to severe COVID-19 progression","volume":"21","author":"Ardestani SK, Salehi MR, Attaran B, Hashemi SM, Sadeghi S, Ghaffarpour S","year":"2022","unstructured":"59. Ardestani SK, Salehi MR, Attaran B, Hashemi SM, Sadeghi S, Ghaffarpour S, Neutrophil to lymphocyte ratio (NLR) and derived NLR combination: a cost-effective predictor of moderate to severe COVID-19 progression, Iran J Allergy Asthma Immunol, 2022;21(3):241-53","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"ref60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.dsx.2021.03.025","article-title":"Evaluation of simple and cost-effective immunohaematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus-A retrospective study in Andhra Pradesh, India","volume":"15","author":"Ramesh J, Reddy SLS, Rajesh M, Varghese J","year":"2021","unstructured":"60. Ramesh J, Reddy SLS, Rajesh M, Varghese J, Evaluation of simple and cost-effective immunohaematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus-A retrospective study in Andhra Pradesh, India, Diabetes Metab Syndr, 2021;15(3):739-45","journal-title":"Diabetes Metab Syndr"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.hrtlng.2024.08.009","article-title":"Predictors of COVID-19 severity in autoimmune disease patients: a retrospective study during full epidemic decontrol in China","volume":"68","author":"Chen LM, Li JB, Wu R","year":"2024","unstructured":"61. Chen LM, Li JB, Wu R, Predictors of COVID-19 severity in autoimmune disease patients: a retrospective study during full epidemic decontrol in China, Heart Lung, 2024;68272-8","journal-title":"Heart Lung"},{"issue":"3","key":"ref62","doi-asserted-by":"publisher","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis","volume":"16","author":"Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D","year":"2021","unstructured":"62. Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis, PLoS One, 2021;16(3):e0247461","journal-title":"PLoS One"},{"issue":"11","key":"ref63","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.numecd.2020.07.031","article-title":"Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST study","volume":"30","author":"Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N","year":"2020","unstructured":"63. Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST study, Nutr Metab Cardiovasc Dis, 2020;30(11):1899-913","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"ref64","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10067-022-06365-y","article-title":"Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses","volume":"41","author":"Mehta P, Gasparyan AY, Zimba O, Kitas GD, Yessirkepov M","year":"2022","unstructured":"64. Mehta P, Gasparyan AY, Zimba O, Kitas GD, Yessirkepov M, Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses, Clin Rheumatol, 2022;41(12):3897-913","journal-title":"Clin Rheumatol"},{"issue":"2","key":"ref65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","article-title":"Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic","volume":"41","author":"Ahmed S, Gasparyan AY, Zimba O","year":"2021","unstructured":"65. Ahmed S, Gasparyan AY, Zimba O, Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic, Rheumatol Int, 2021;41(2):243-56","journal-title":"Rheumatol Int"},{"issue":"8","key":"ref66","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1136\/ard-2023-224080","article-title":"Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registry","volume":"82","author":"Bergstra SA, Sepriano A, Chopra A, Winchow LL, Vega-Morales D, Salomon-Escoto K","year":"2023","unstructured":"66. Bergstra SA, Sepriano A, Chopra A, Winchow LL, Vega-Morales D, Salomon-Escoto K, Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registry, Ann Rheum Dis, 2023;82(8):1018-24","journal-title":"Ann Rheum Dis"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"152635","DOI":"10.1016\/j.semarthrit.2025.152635","article-title":"Age of onset of rheumatoid arthritis and radiographic changes","volume":"71","author":"Shimizu M, Paudel ML, Shadick N, Weinblatt M, Solomon DH","year":"2025","unstructured":"67. Shimizu M, Paudel ML, Shadick N, Weinblatt M, Solomon DH, Age of onset of rheumatoid arthritis and radiographic changes, Semin Arthritis Rheum, 2025;71152635","journal-title":"Semin Arthritis Rheum"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"100143","DOI":"10.1016\/j.jtauto.2022.100143","article-title":"Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies","volume":"5","author":"Irure-Ventura J, L\u00f3pez-Hoyos M","year":"2022","unstructured":"68. Irure-Ventura J, L\u00f3pez-Hoyos M, Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies, J Transl Autoimmun, 2022;5100143","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"ref69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai X, Fan Y, Zhao X","year":"2025","unstructured":"69. Dai X, Fan Y, Zhao X, Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics, Signal Transduct Target Ther, 2025;10(1):102","journal-title":"Signal Transduct Target Ther"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1759720X211073001","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima A, Jurcut C, Chasset F, Felten R, Arnaud L","year":"2022","unstructured":"70. Dima A, Jurcut C, Chasset F, Felten R, Arnaud L, Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge, Ther Adv Musculoskelet Dis, 2022;141759720X211073001","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"ref71","doi-asserted-by":"publisher","first-page":"e1004428","DOI":"10.1371\/journal.pmed.1004428","article-title":"Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): a double-blind, randomised, placebo-controlled trial","volume":"21","author":"Schilling WHK, Mukaka M, Callery JJ, Llewelyn MJ, Cruz CV, Dhorda M","year":"2024","unstructured":"71. Schilling WHK, Mukaka M, Callery JJ, Llewelyn MJ, Cruz CV, Dhorda M, Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): a double-blind, randomised, placebo-controlled trial, PLoS Med, 2024;21(9):e1004428","journal-title":"PLoS Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France","volume":"35","author":"Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S","year":"2020","unstructured":"72. Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, Travel Med Infect Dis, 2020;35101738","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"ref73","doi-asserted-by":"publisher","first-page":"e065305","DOI":"10.1136\/bmjopen-2022-065305","article-title":"Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials","volume":"13","author":"Hong H, Friedland A, Hu M, Anstrom KJ, Halabi S, McKinnon JE","year":"2023","unstructured":"73. Hong H, Friedland A, Hu M, Anstrom KJ, Halabi S, McKinnon JE, Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials, BMJ Open, 2023;13(6):e065305","journal-title":"BMJ Open"},{"issue":"21","key":"ref74","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19","volume":"383","author":"RECOVERY Collaborative Group","year":"2020","unstructured":"74. RECOVERY Collaborative Group, Effect of hydroxychloroquine in hospitalized patients with COVID-19, N Engl J Med, 2020;383(21):2030-40","journal-title":"N Engl J Med"},{"issue":"4","key":"ref75","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s40121-021-00517-4","article-title":"Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial","volume":"10","author":"Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I","year":"2021","unstructured":"75. Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial, Infect Dis Ther, 2021;10(4):2489-509","journal-title":"Infect Dis Ther"},{"issue":"3","key":"ref76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.55940\/medphar202344","article-title":"Favipiravir: emergent antiviral drug during COVID-19","volume":"2","author":"Kumar K, Vidyadhara S, Babu J","year":"2023","unstructured":"76. Kumar K, Vidyadhara S, Babu J, Favipiravir: emergent antiviral drug during COVID-19, Med Pharm J, 2023;2(3):175-80","journal-title":"Med Pharm J"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-8-2026\/original-article-issue-8-2026\/covid-19-severity-and-early-inflammatory-biomarkers-in-patients-with-immune-mediated-inflammatory-rheumatic-diseases-a-multicenter-cohort-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:05:47Z","timestamp":1792991147000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-8-2026\/original-article-issue-8-2026\/covid-19-severity-and-early-inflammatory-biomarkers-in-patients-with-immune-mediated-inflammatory-rheumatic-diseases-a-multicenter-cohort-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["JMedLife-19-657"],"URL":"https:\/\/doi.org\/10.25122\/jml-2026-0098","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}